Marine Brown Algae-Derived Bioactive Polysaccharide Fucoidans
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals".
Deadline for manuscript submissions: 15 June 2025 | Viewed by 143
Special Issue Editor
Interests: marine brown algae; polysaccharides; fucoidan; bioactivity; medical; fucoidan in human clinical trials; cosmetics; nutraceuticals
Special Issue Information
Dear Colleagues,
The ocean occupies about 70% of the earth’s surface area, 95% of the earth's total biosphere volume, and is the largest habitat for life so far. Similarly to land plants, algae are at the base of the food chain in oceans, and most brown algae live in marine environments and play an important role both as food sources as well as potential habitats.
Brown algae, a kind of marine macroalgae in the class Phaeophyceae, consist of more than 250 genera and about 2000 species. Carbohydrates (or glycans) are one of the natural biomolecules. Among carbohydrates in brown algae, polysaccharides are the most abundant bioactive substances. The fucoidan, a kind of sulfated polysaccharide in cell walls, mainly from brown seaweed, includes a substantial percentage of L-fucose. Fucoidan has various biological and pharmacological bio-activities, such as anticancer/antitumor, anti-proliferation, anti-inflammatory, and immune-modulatory functions, and fucoidan-related dietary supplements and nutraceuticals have recently drawn considerable attention.
In this Special Issue, we will focus on the applications of bioactivity of marine brown algae-derived fucoidan in the development of specific medical, cosmetic, nutraceutical, and biotechnological products. In addition, fucoidan in human clinical trials of certain diseases will be discussed.
As Guest Editor, I invite scientists and experts in this interdisciplinary area of marine brown algae-derived fucoidan to contribute their latest research findings and review articles in the form of high-quality manuscripts. I am sure that your great efforts will lead to significant progress in this highly promising fucoidan-related research area.
Prof. Dr. Hsien-Yeh Hsu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine brown algae-derived fucoidan
- polysaccharides
- bioactivity
- medical
- fucoidan in human clinical trials
- cosmetics
- nutraceuticals
- biotechnological
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
